These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10363970)
1. Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue. Bièche I; Lidereau R Cancer Res; 1999 Jun; 59(11):2546-50. PubMed ID: 10363970 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of BRCA2 gene in sporadic breast tumours. Bièche I; Noguès C; Lidereau R Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873 [TBL] [Abstract][Full Text] [Related]
3. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Dotzlaw H; Leygue E; Watson P; Murphy LC Clin Cancer Res; 1999 Aug; 5(8):2103-7. PubMed ID: 10473093 [TBL] [Abstract][Full Text] [Related]
4. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma. Girault I; Andrieu C; Tozlu S; Spyratos F; Bièche I; Lidereau R Cancer Lett; 2004 Nov; 215(1):101-12. PubMed ID: 15374639 [TBL] [Abstract][Full Text] [Related]
5. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue. Yang T; Zhang JS; Massa SM; Han X; Longo FM Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues. Fasco MJ Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786 [TBL] [Abstract][Full Text] [Related]
8. Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer. Nagao K; Kohno N; Wakita K; Hikiji K; Yamamoto S; Hirata H; Hisatomi H Oncol Rep; 2003; 10(2):305-8. PubMed ID: 12579263 [TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Pfeffer U; Fecarotta E; Castagnetta L; Vidali G Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651 [TBL] [Abstract][Full Text] [Related]
11. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Lu M; Conzen SD; Cole CN; Arrick BA Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines. Bernard-Gallon DJ; Vissac-Sabatier C; Antoine-Vincent D; Rio PG; Maurizis JC; Fustier P; Bignon YJ Br J Nutr; 2002 Apr; 87(4):281-9. PubMed ID: 12064337 [TBL] [Abstract][Full Text] [Related]
13. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Ghadersohi A; Sood AK Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586 [TBL] [Abstract][Full Text] [Related]
14. Alternatively spliced, truncated human BRCA2 isoforms contain a novel coding exon. Speevak MD; Young SS; Feilotter H; Ainsworth P Eur J Hum Genet; 2003 Dec; 11(12):951-4. PubMed ID: 14647209 [TBL] [Abstract][Full Text] [Related]
15. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508 [TBL] [Abstract][Full Text] [Related]
16. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Jäger D; Stockert E; Güre AO; Scanlan MJ; Karbach J; Jäger E; Knuth A; Old LJ; Chen YT Cancer Res; 2001 Mar; 61(5):2055-61. PubMed ID: 11280766 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients. Gebhardt F; Zänker KS; Brandt B Biochem Biophys Res Commun; 1998 Jun; 247(2):319-23. PubMed ID: 9642124 [TBL] [Abstract][Full Text] [Related]
18. Structure and expression of variant BRCA2a lacking the transactivation domain. Zou JP; Hirose Y; Siddique H; Rao VN; Reddy ES Oncol Rep; 1999; 6(2):437-40. PubMed ID: 10023017 [TBL] [Abstract][Full Text] [Related]
19. Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells. Jiang X; Russo IH; Russo J Int J Oncol; 2002 Apr; 20(4):735-8. PubMed ID: 11894118 [TBL] [Abstract][Full Text] [Related]
20. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2. Sorg RV; Enczmann J; Sorg UR; Schneider EM; Wernet P Exp Hematol; 1993 Apr; 21(4):560-3. PubMed ID: 8462665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]